Beike Forms JV to Deliver Stem Cell Therapies throughout Asia

Shenzhen Beike Biotechnology has formed a JV with SiriCell Technologies of Bangkok, a fellow stem cell company. Beike Holdings Limited, as the JV is called, will focus on building international subsidiaries of Beike and developing partnerships with hospitals throughout Southeast Asia. The ultimate goal is to expand the reach of Beike’s stem cell therapies, currently available only in China, throughout Asia. More details...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.